Plastomitin (SkQ1 pill)
/ Mitotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 11, 2020
Prevention of Diastolic Dysfunction Caused by Doxorubicin by Mitochondrial Antioxidant Plastomitin
(PubMed, Kardiologiia)
- "Left ventricular function was evaluated with echocardiography (EchoCG) and cardiac catheterization with simultaneous pressure and volume monitoring.Results According to EchoCG data the ejection fraction remained unchanged in the experimental groups. Cardiac catheterization showed disorders of both myocardial contractility and relaxability only in the doxorubicin group.Conclusion A course of plastomitin in combination with the doxorubicin treatment can maintain normal heart contractility and thereby, prevent the known doxorubicin cardiotoxicity."
Journal • Cardiomyopathy • Cardiovascular • Congestive Heart Failure • Heart Failure
June 28, 2019
Mitochondrial Antioxidant Plastomitin Improves Cardiac Function in Doxorubicin-Induced Cardiomyopathy
(PubMed, Kardiologiia)
- "This method of compensation is more beneficial for the body, because it does not restrict the supply of organs and tissues with oxygen, and has significant advantage over doxorubicin group at equal heart rate. Conclusion. The results allow to conclude that the use of plastomitin together with doxorubicin prevents the development of doxorubicin-induced systolic dysfunction."
Journal
1 to 2
Of
2
Go to page
1